- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05180786
Error-enhanced Learning & Recovery in 2 & 3 Dimensions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The neuroplasticity of motor re-learning is a key pathway for recovery in neurorehabilitation. One critical challenge to devising treatment plans for motor recovery is the wide variation that exists between individuals, across movement repetitions, and even within movements. Development of a learning model that looks at these factors would better relate diagnoses to treatments, providing personalization and efficiency to therapy. This proposal aims to advance rehabilitation by building a modeling framework that explores the trends and exploits a fundamental learning process - error. Our goal is to preliminarily test the direct effect of this new treatment in preparation for the randomized controlled study to come. Understanding how error leads to better performance will help us program future devices for therapy for optimal outcomes.
We are using research lab equipment at the Shirley Ryan AbilityLab (SRALab) Hospital's Robotics group. The equipment will be used to implement the reaching exercises and measure participant movement. The equipment includes:
- Barret b.u.r.t. arm robot with Teneo forearm attachment
- LookingGlass virtual reality display system
- Garmin Venu Sq fitness tracking wristwatch
Study Outline:
Week 1, Visit 1: Consent, In-Person Screening, and Baseline Evaluations Participants will sign a consent form. Then, they will undergo a screening process to check if they meet all the eligibility requirements. Participants that pass the in-person screening and agree to continue with the study will complete baseline evaluations which will consistent of upper extremity outcome measures, and a preliminary reaching experiment on the b.u.r.t. robotic arm.
Weeks 2-3, Visits 2-7: Treatment Visits In the following two weeks, participants will come to the lab three times a week. They will use the robotic arm, and complete several rounds of reaching exercises while looking in the virtual reality display system. Depending on the treatment visit, participants will either take home a fitness tracker, or be asked to return it.
Week 4, Visit 8: Post-Evaluations About a week after the treatment sessions, participants will return to the lab and complete the same evaluations they completed during visit 1 to see if there is any change.
Weeks 5-8: There will be no lab visits during this time.
Week 9, Visit 9: About 5-6 weeks after the treatment visits, participants will come back for follow-up evaluations. These will be the same outcome measures completed during the baseline and post-evaluation sessions.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Courtney Celian
- Phone Number: 3122381560
- Email: ccelian@sralab.org
Study Contact Backup
- Name: Naveed Aghamohammadi
- Phone Number: 7654215544
- Email: nagham2@uic.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Shirley Ryan AbilityLab
-
Contact:
- Courtney Celian, MS
-
Principal Investigator:
- James Patton, PhD
-
Chicago, Illinois, United States, 60611
- Recruiting
- Shirley Ryan AbilityLab (Healthy Participants)
-
Contact:
- Naveed Aghamohammadi
- Phone Number: 765-421-5544
- Email: nagham2@uic.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
- Hemiparesis
- Some degree of both shoulder and elbow movement capability
Exclusion Criteria:
- Bilateral paresis
- Severe tactile deficits using the Two-Point Discrimination Test (participant must detect<11mm)
- Severe proprioceptive deficits
- Severe spasticity (Modified Ashworth >3) preventing movement
- Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
- Visual deficits, and hemispatial neglect that would prevent the subjects from seeing the targets.
- Inability to provide an informed consent
- severe current medical problems
- diffuse/multiple lesion sites or multiple stroke events
- Inability to attain and maintain testing positions
- Botox injection to the affected upper extremity within the previous 4 months
- Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy
- Participation in previous, similar robotics intervention study
- Other neurological issues
None of the following special populations will be included in this research study:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Vulnerable Populations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group 1
|
Participants will complete a reaching experiment using the robotic arm with error fields turned on.
Participants will complete a reaching experiment using the robotic arm with error fields turned off.
|
|
Other: Group 2
|
Participants will complete a reaching experiment using the robotic arm with error fields turned on.
Participants will complete a reaching experiment using the robotic arm with error fields turned off.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Perpendicular Error
Time Frame: 60-90 minutes
|
60-90 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Action Research Arm Test
Time Frame: 5-20 minutes
|
5-20 minutes
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Upper Extremity portion of the Fugl-Meyer
Time Frame: 5-20 minutes
|
5-20 minutes
|
|
Box and Blocks
Time Frame: 5-20 minutes
|
5-20 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: James Patton, PhD, Shirley Ryan AbilityLab
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00215000
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on Error Fields
-
Shirley Ryan AbilityLabNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...Completed
-
Shirley Ryan AbilityLabU.S. Department of EducationCompleted
-
Stanford UniversityThe University of Texas Health Science Center, Houston; University of California... and other collaboratorsCompletedLearning | Adaptive Expertise | Error Management TrainingUnited States
-
Joslin Diabetes CenterJuvenile Diabetes Research FoundationCompleted
-
McGill UniversityCanadian Institutes of Health Research (CIHR); Centre for Interdisciplinary... and other collaboratorsRecruitingCognitive Impairment | Stroke, Ischemic | Stroke HemorrhagicCanada
-
VA Office of Research and DevelopmentCompleted
-
Hillerod Hospital, DenmarkThe Lundbeckfoundation; BiofieldsCompleted
-
VA Office of Research and DevelopmentRecruitingDiabetes Mellitus | Peripheral Artery Disease | Transtibial AmputationUnited States
-
Pamukkale UniversityCompleted
-
European Georges Pompidou HospitalUnknownEmbolism | Pulmonary Embolism | Pulmonary Vascular Disorder | Pulmonary Embolism and Thrombosis | Diagnostic ErrorsFrance